These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

71 related articles for article (PubMed ID: 13435494)

  • 21. Acceptance for preventive genetic testing and prophylactic surgery in women with a family history of breast and gynaecological cancers.
    Ackermann S; Lux MP; Fasching PA; Strissl P; Renner SP; Poehls U; Bender HG; Beckmann MW
    Eur J Cancer Prev; 2006 Dec; 15(6):474-9. PubMed ID: 17106324
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The predominant role of surgery in the prevention and new trends in the surgical treatment of women with BRCA1/2 mutations.
    Fatouros M; Baltoyiannis G; Roukos DH
    Ann Surg Oncol; 2008 Jan; 15(1):21-33. PubMed ID: 17940826
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group.
    Rebbeck TR; Friebel T; Lynch HT; Neuhausen SL; van 't Veer L; Garber JE; Evans GR; Narod SA; Isaacs C; Matloff E; Daly MB; Olopade OI; Weber BL
    J Clin Oncol; 2004 Mar; 22(6):1055-62. PubMed ID: 14981104
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer.
    Meiser B; Butow P; Price M; Bennett B; Berry G; Tucker K;
    J Womens Health (Larchmt); 2003 Oct; 12(8):769-78. PubMed ID: 14588127
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Breast cancer risk following bilateral oophorectomy in BRCA1 and BRCA2 mutation carriers: an international case-control study.
    Eisen A; Lubinski J; Klijn J; Moller P; Lynch HT; Offit K; Weber B; Rebbeck T; Neuhausen SL; Ghadirian P; Foulkes WD; Gershoni-Baruch R; Friedman E; Rennert G; Wagner T; Isaacs C; Kim-Sing C; Ainsworth P; Sun P; Narod SA
    J Clin Oncol; 2005 Oct; 23(30):7491-6. PubMed ID: 16234515
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
    Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
    J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
    [No Abstract]   [Full Text] [Related]  

  • 27. Increasing use of contralateral prophylactic mastectomy for breast cancer patients: a trend toward more aggressive surgical treatment.
    Tuttle TM; Habermann EB; Grund EH; Morris TJ; Virnig BA
    J Clin Oncol; 2007 Nov; 25(33):5203-9. PubMed ID: 17954711
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Laparoscopic prophylactic oophorectomy plus N3 lymphadenectomy for advanced rectosigmoid cancer.
    Liang JT; Lai HS; Wu CT; Huang KC; Lee PH; Shun CT
    Ann Surg Oncol; 2007 Jul; 14(7):1991-9. PubMed ID: 17447107
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Breast cancer: endocrine therapy and gynecological surgery].
    BRICENO RI
    Rev Obstet Ginecol Venez; 1954; 14(4):669-78. PubMed ID: 14372494
    [No Abstract]   [Full Text] [Related]  

  • 30. Prophylactic bilateral salpingo-oophorectomy (PBSO) with or without prophylactic bilateral mastectomy (PBM) or no intervention in BRCA1 mutation carriers: a cost-effectiveness analysis.
    Norum J; Hagen AI; Maehle L; Apold J; Burn J; Møller P
    Eur J Cancer; 2008 May; 44(7):963-71. PubMed ID: 18362067
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Oophorectomy & adrenalectomy in metastatic cancer of the breast].
    HELLSTROM J
    Nord Med; 1958 Jun; 59(23):769-73. PubMed ID: 13566571
    [No Abstract]   [Full Text] [Related]  

  • 32. [Ovariectomy in the treatment of advanced breast carcinoma].
    Ostojić M; Merkas M; Bosković M
    Srp Arh Celok Lek; 1971; 99(4):283-7. PubMed ID: 5140936
    [No Abstract]   [Full Text] [Related]  

  • 33. [Prophylactic mastectomy in women at high risk for breast and ovarian cancer: qualitative analysis of the decision making process and long-term satisfaction of two women carrying a BRCA1-mutation].
    Vodermaier A; Bauerfeind I; Untch M; Nestle-Krämling C
    Psychother Psychosom Med Psychol; 2006; 56(9-10):351-61. PubMed ID: 16804803
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Surgical risk reduction: prophylactic salpingo-oophorectomy and prophylactic mastectomy.
    Dowdy SC; Stefanek M; Hartmann LC
    Am J Obstet Gynecol; 2004 Oct; 191(4):1113-23. PubMed ID: 15507929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The course of distress in women at increased risk of breast and ovarian cancer due to an (identified) genetic susceptibility who opt for prophylactic mastectomy and/or salpingo-oophorectomy.
    Bresser PJ; Seynaeve C; Van Gool AR; Niermeijer MF; Duivenvoorden HJ; van Dooren S; van Geel AN; Menke-Pluijmers MB; Klijn JG; Tibben A
    Eur J Cancer; 2007 Jan; 43(1):95-103. PubMed ID: 17095208
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Contentment with quality of life among breast cancer survivors with and without contralateral prophylactic mastectomy.
    Geiger AM; West CN; Nekhlyudov L; Herrinton LJ; Liu IL; Altschuler A; Rolnick SJ; Harris EL; Greene SM; Elmore JG; Emmons KM; Fletcher SW
    J Clin Oncol; 2006 Mar; 24(9):1350-6. PubMed ID: 16549829
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary peritoneal serous carcinoma presenting as inflammatory breast cancer.
    Khalifeh I; Deavers MT; Cristofanilli M; Coleman RL; Malpica A; Gilcrease MZ
    Breast J; 2009; 15(2):176-81. PubMed ID: 19292804
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Too much, too soon? Patients and health professionals' views concerning the impact of genetic testing at the time of breast cancer diagnosis in women under the age of 40.
    Ardern-Jones A; Kenen R; Eeles R
    Eur J Cancer Care (Engl); 2005 Jul; 14(3):272-81. PubMed ID: 15952973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Survival after adjuvant oophorectomy and tamoxifen in operable breast cancer in premenopausal women.
    Love RR; Van Dinh N; Quy TT; Linh ND; Tung ND; Shen TZ; Hade EM; Young GS; Jarjoura D
    J Clin Oncol; 2008 Jan; 26(2):253-7. PubMed ID: 18086800
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The risk of ovarian cancer after breast cancer in BRCA1 and BRCA2 carriers.
    Metcalfe KA; Lynch HT; Ghadirian P; Tung N; Olivotto IA; Foulkes WD; Warner E; Olopade O; Eisen A; Weber B; McLennan J; Sun P; Narod SA
    Gynecol Oncol; 2005 Jan; 96(1):222-6. PubMed ID: 15589605
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.